LINC00955 and colorectal carcinoma: In conclusion, LINC00955 is downregulated in CRC and inhibits CRC cell proliferation by acting as a molecular scaffold of TRIM25 and Sp1 to inhibit the DNMT3B/PHIP/CDK2 axis.